BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21970305)

  • 1. Treatment of dementia with Lewy bodies and Parkinson's disease dementia.
    Ballard C; Kahn Z; Corbett A
    Drugs Aging; 2011 Oct; 28(10):769-77. PubMed ID: 21970305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors for dementia with Lewy bodies.
    Wild R; Pettit T; Burns A
    Cochrane Database Syst Rev; 2003; 2003(3):CD003672. PubMed ID: 12917981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.
    Aarsland D; Ballard C; Rongve A; Broadstock M; Svenningsson P
    Curr Neurol Neurosci Rep; 2012 Oct; 12(5):492-501. PubMed ID: 22806065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D; Mosimann UP; McKeith IG
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):164-71. PubMed ID: 15312280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's Disease Dementia and Lewy Body Disease.
    Sezgin M; Bilgic B; Tinaz S; Emre M
    Semin Neurol; 2019 Apr; 39(2):274-282. PubMed ID: 30925619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ; Broe GA; Halliday GM
    Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management.
    Ballard C; Aarsland D; Francis P; Corbett A
    Drugs Aging; 2013 Aug; 30(8):603-11. PubMed ID: 23681401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies.
    Camicioli R; Gauthier S
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S109-17. PubMed ID: 17469693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of dementia with Lewy bodies.
    Fernandez HH; Wu CK; Ott BR
    Expert Opin Pharmacother; 2003 Nov; 4(11):2027-37. PubMed ID: 14596656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease.
    Burn DJ; McKeith IG
    Mov Disord; 2003 Sep; 18 Suppl 6():S72-9. PubMed ID: 14502659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia with Lewy bodies and Parkinson's disease.
    McKeith IG; Mosimann UP
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S15-8. PubMed ID: 15109582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.